181 related articles for article (PubMed ID: 11097222)
1. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine.
Lawson KR; Ignatenko NA; Piazza GA; Cui H; Gerner EW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1155-62. PubMed ID: 11097222
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
[TBL] [Abstract][Full Text] [Related]
3. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
4. The new sulindac derivative IND 12 reverses Ras-induced cell transformation.
Karaguni IM; Herter P; Debruyne P; Chtarbova S; Kasprzynski A; Herbrand U; Ahmadian MR; Glüsenkamp KH; Winde G; Mareel M; Möröy T; Müller O
Cancer Res; 2002 Mar; 62(6):1718-23. PubMed ID: 11912145
[TBL] [Abstract][Full Text] [Related]
5. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells.
Taylor MT; Lawson KR; Ignatenko NA; Marek SE; Stringer DE; Skovan BA; Gerner EW
Cancer Res; 2000 Dec; 60(23):6607-10. PubMed ID: 11118042
[TBL] [Abstract][Full Text] [Related]
6. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
7. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
Mariadason JM; Corner GA; Augenlicht LH
Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells.
Seo SK; Jin HO; Lee HC; Woo SH; Kim ES; Yoo DH; Lee SJ; An S; Rhee CH; Hong SI; Choe TB; Park IC
Mol Pharmacol; 2008 Mar; 73(3):1005-12. PubMed ID: 18156316
[TBL] [Abstract][Full Text] [Related]
9. The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells.
Ignatenko NA; Zhang H; Watts GS; Skovan BA; Stringer DE; Gerner EW
Mol Carcinog; 2004 Apr; 39(4):221-33. PubMed ID: 15057874
[TBL] [Abstract][Full Text] [Related]
10. A quantitative angiogenesis model for efficacy testing of chemopreventive agents.
Sharma S; Ghoddoussi M; Gao P; Kelloff GJ; Steele VE; Kopelovich L
Anticancer Res; 2001; 21(6A):3829-37. PubMed ID: 11911254
[TBL] [Abstract][Full Text] [Related]
11. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats.
Fong LY; Nguyen VT; Pegg AE; Magee PN
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):191-9. PubMed ID: 11303587
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
13. Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.
Waldmann H; Karaguni IM; Carpintero M; Gourzoulidou E; Herrmann C; Brockmann C; Oschkinat H; Müller O
Angew Chem Int Ed Engl; 2004 Jan; 43(4):454-8. PubMed ID: 14735533
[No Abstract] [Full Text] [Related]
14. Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.
Müller O; Gourzoulidou E; Carpintero M; Karaguni IM; Langerak A; Herrmann C; Möröy T; Klein-Hitpass L; Waldmann H
Angew Chem Int Ed Engl; 2004 Jan; 43(4):450-4. PubMed ID: 14735532
[No Abstract] [Full Text] [Related]
15. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.
Gerner EW; Meyskens FL; Goldschmid S; Lance P; Pelot D
Amino Acids; 2007 Aug; 33(2):189-95. PubMed ID: 17396214
[TBL] [Abstract][Full Text] [Related]
16. Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKbeta.
Seo AM; Hong SW; Shin JS; Park IC; Hong NJ; Kim DJ; Lee WK; Lee WJ; Jin DH; Lee MS
Apoptosis; 2009 Jul; 14(7):913-22. PubMed ID: 19526344
[TBL] [Abstract][Full Text] [Related]
17. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC.
Chang WC; Everley LC; Pfeiffer GR; Cooper HS; Barusevicius A; Clapper ML
Ann N Y Acad Sci; 2005 Nov; 1059():41-55. PubMed ID: 16382042
[TBL] [Abstract][Full Text] [Related]
18. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Berman KS; Verma UN; Harburg G; Minna JD; Cobb MH; Gaynor RB
Clin Cancer Res; 2002 Feb; 8(2):354-60. PubMed ID: 11839649
[TBL] [Abstract][Full Text] [Related]
19. Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice.
Mackenzie GG; Ouyang N; Xie G; Vrankova K; Huang L; Sun Y; Komninou D; Kopelovich L; Rigas B
Cancer Prev Res (Phila); 2011 Jul; 4(7):1052-60. PubMed ID: 21464038
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
